{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:09:16Z","timestamp":1777950556891,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","award":["4459"],"award-info":[{"award-number":["4459"]}],"id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"publisher","award":["4459"],"award-info":[{"award-number":["4459"]}],"id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["179890"],"award-info":[{"award-number":["179890"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10549-026-07943-3","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:57:35Z","timestamp":1774943855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival"],"prefix":"10.1007","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0044-7545","authenticated-orcid":false,"given":"Kathleen M.","family":"Decker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3355-2861","authenticated-orcid":false,"given":"Allison","family":"Feely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1858-5081","authenticated-orcid":false,"given":"Marshall","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-2779","authenticated-orcid":false,"given":"Pamela","family":"Hebbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-2024","authenticated-orcid":false,"given":"Julian O.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9152-8815","authenticated-orcid":false,"given":"Piotr","family":"Czaykowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-2356","authenticated-orcid":false,"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-9451","authenticated-orcid":false,"given":"Oliver","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2640-3349","authenticated-orcid":false,"given":"Grace","family":"Musto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-7591","authenticated-orcid":false,"given":"Pascal","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"4","key":"7943_CR1","first-page":"241","volume":"74","author":"K Osowiecjam","year":"2024","unstructured":"Osowiecjam K, Mieszala K, Olejniczak D, Rucinska M (2024) Breast cancer treatment during the COVID-19 pandemic\u2014a patient\u2019s perspective. Nowotwory J Oncol 74(4):241\u2013253","journal-title":"Nowotwory J Oncol"},{"issue":"2","key":"7943_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0969141320974711","volume":"28","author":"JH Yong","year":"2021","unstructured":"Yong JH, Mainprize JG, Yaffe MJ, Ruan Y, Poirier AE, Coldman A et al (2021) The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada. J Med Screen 28(2):100\u2013107","journal-title":"J Med Screen"},{"issue":"8","key":"7943_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ijc.33884","volume":"150","author":"T Malagon","year":"2022","unstructured":"Malagon T, Yong JHE, Tope P, Miller WH Jr., Franco EL, McGill Task Force on the Impact of C-oCC et al (2022) Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. Int J Cancer 150(8):1244\u20131254","journal-title":"Int J Cancer"},{"issue":"8","key":"7943_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","volume":"21","author":"C Maringe","year":"2020","unstructured":"Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21(8):1023\u20131034","journal-title":"Lancet Oncol"},{"issue":"3","key":"7943_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-020-05644-z","volume":"181","author":"JR Dietz","year":"2020","unstructured":"Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ et al (2020) Recommendations for prioritization: treatment and triage of breast cancer patients during the COVID-19 pandemic the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 181(3):487\u2013497","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7943_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3747\/co.27.6699","volume":"27","author":"D Berger-Richardson","year":"2020","unstructured":"Berger-Richardson D, Ko G, Hong NJL (2020) Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system. Curr Oncol 27(3):163\u2013168","journal-title":"Curr Oncol"},{"key":"7943_CR7","first-page":"51","volume":"15","author":"A Prodhan","year":"2023","unstructured":"Prodhan A, Islam DZ, Khandker SS, Jamiruddin MR, Abdullah A, Godman B et al (2023) Breast cancer management in the era of Covid-19; key issues, contemporary strategies, and future implications. Breast Cancer (Dove Med Press) 15:51\u201389","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"4","key":"7943_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.adro.2020.04.013","volume":"5","author":"S Rathod","year":"2020","unstructured":"Rathod S, Dubey A, Chowdhury A, Bashir B, Koul R (2020) A call for a radiation oncology model based on new 4R\u2019s during the COVID-19 pandemic. Adv Radiat Oncol 5(4):608\u2013609","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"7943_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","volume":"16","author":"IH Kunkler","year":"2015","unstructured":"Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM, investigators PI (2015) Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 16(3):266\u2013273","journal-title":"Lancet Oncol"},{"issue":"1","key":"7943_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/curroncol28010026","volume":"28","author":"R Rittberg","year":"2020","unstructured":"Rittberg R, Mann A, Desautels D, Earle CC, Navaratnam S, Pitz M (2020) Canadian cancer centre response to COVID-19 pandemic: a national and provincial response. Curr Oncol 28(1):233\u2013251","journal-title":"Curr Oncol"},{"key":"7943_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.106961","volume":"155","author":"KM Decker","year":"2022","unstructured":"Decker KM, Feely A, Bucher O, Singh H, Turner D, Lambert P (2022) Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province. Prev Med 155:106961","journal-title":"Prev Med"},{"issue":"1","key":"7943_CR12","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A (2017) Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 46(1):348\u2013355","journal-title":"Int J Epidemiol"},{"key":"7943_CR13","unstructured":"North American Association of Central Cancer Registries (2006) Appendix C - data quality indicators by year and registry. In: Hotes Ellison J, Wu XC, McLaughlin C, Lake A, Firth R, Cormier M (ed) Cancer in North America: 1999\u20132003 Volume One: Incidence: North American Association of Central Cancer Registries"},{"key":"7943_CR14","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/sim.1203","volume":"21","author":"P Royston","year":"2002","unstructured":"Royston P, Parmar MKB (2002) Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21:2175\u20132197","journal-title":"Stat Med"},{"issue":"19","key":"7943_CR15","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.4274","volume":"30","author":"P Royston","year":"2011","unstructured":"Royston P, Parmar MK (2011) The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med 30(19):2409\u20132421","journal-title":"Stat Med"},{"key":"7943_CR16","unstructured":"Hartig F (2022) DHARMa: residual diagnostics for hierarchical (multi-level\/ mixed) regression models. R package version 0.4.5. Regensburg, Germany"},{"key":"7943_CR17","unstructured":"Wickham H, Miller E, Smith D (2023) haven: import and export 'SPSS', 'Stata' and 'SAS' files. In: 2.5.4 Rpv, editor"},{"key":"7943_CR18","unstructured":"Harrell FE (2023) Package Hmisc. https:\/\/cran.r-project.org\/web\/packages\/Hmisc\/Hmisc.pdf"},{"key":"7943_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-0-387-75969-2","volume-title":"Lattice: multivariate data visualization with R","author":"D Sarkar","year":"2008","unstructured":"Sarkar D (2008) Lattice: multivariate data visualization with R. Springer, New York, p 273"},{"key":"7943_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) ggplot2: elegant graphics for data analysis. Springer, New York, p 260"},{"issue":"3","key":"7943_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bimj.200810425","volume":"50","author":"T Hothorn","year":"2008","unstructured":"Hothorn T, Bretz F, Westfall P (2008) Simultaneous inference in general parametric models. Biom J 50(3):346\u2013363","journal-title":"Biom J"},{"issue":"3","key":"7943_CR22","first-page":"7","volume":"2","author":"A Zeileis","year":"2002","unstructured":"Zeileis A, Hothorn T (2002) Diagnostic checking in regression relationships. R News 2(3):7\u201310","journal-title":"R News"},{"issue":"5","key":"7943_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/0962280216664760","volume":"27","author":"X Liu","year":"2018","unstructured":"Liu X, Pawitan Y, Clements M (2018) Parametric and penalized generalized survival models. Stat Methods Med Res 27(5):1531\u20131546","journal-title":"Stat Methods Med Res"},{"key":"7943_CR24","volume-title":"An R companion to applied regression","author":"J Fox","year":"2019","unstructured":"Fox J, Weisberg S (2019) An R companion to applied regression, 3rd edn. Sage, Thousand Oaks","edition":"3"},{"issue":"4","key":"7943_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmir.2024.04.012","volume":"55","author":"L Zychla","year":"2024","unstructured":"Zychla L, Given MR (2024) An MRT workforce shortage is no laughing matter. J Med Imaging Radiat Sci 55(4):101419","journal-title":"J Med Imaging Radiat Sci"},{"key":"7943_CR26","unstructured":"Manitoba Government Helping More Women Get Screened for Breast Cancer [press release]. Winnipeg, MB: Government of Manitoba 2024"},{"key":"7943_CR27","unstructured":"Public Heath England (2016) NHS breast screening programme national radiographic workforce survey 2016. London, UK"},{"key":"7943_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/jbi\/wbaf031","author":"S Bhole","year":"2025","unstructured":"Bhole S, Grimm LJ, Parikh JR, Dontchos BN, Reig B, Jacobs SA et al (2025) Breast imaging staffing shortages: defining the problem and addressing root causes. J Breast Imaging. https:\/\/doi.org\/10.1093\/jbi\/wbaf031","journal-title":"J Breast Imaging"},{"issue":"1","key":"7943_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10549-024-07547-9","volume":"210","author":"G Ko","year":"2025","unstructured":"Ko G, Li Q, Liu N, Amir E, Covelli A, Eskander A et al (2025) Impact of the COVID-19 pandemic on breast cancer surgeries in a Canadian population. Breast Cancer Res Treat 210(1):147\u2013156","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"7943_CR30","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41416-020-01234-4","volume":"124","author":"RV Dave","year":"2021","unstructured":"Dave RV, Kim B, Courtney A, O\u2019Connell R, Rattay T, Taxiarchi VP et al (2021) Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK \u201cAlert level 4\u201d phase of the B-MaP-C study. Br J Cancer 124(11):1785\u20131794","journal-title":"Br J Cancer"},{"key":"7943_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32050247","author":"AA Lopez Rios","year":"2025","unstructured":"Lopez Rios AA, Dozois A, Johnson AT, Canturk T, Zhang J (2025) COVID-19 pandemic\u2019s effects on breast cancer screening, staging at diagnosis at presentation, oncologic management, and immediate reconstruction: a Canadian perspective. Curr Oncol. https:\/\/doi.org\/10.3390\/curroncol32050247","journal-title":"Curr Oncol"},{"issue":"1","key":"7943_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/curroncol28010026","volume":"28","author":"R Rittberg","year":"2020","unstructured":"Rittberg R, Mann A, Desautels D, Earle CC, Navaratnam S, Pitz M (2020) Canadian cancer ccentre response to COVID-19 pandemic: a national and provincial response. Curr Oncol 28(1):233\u2013251","journal-title":"Curr Oncol"},{"issue":"4","key":"7943_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.adro.2020.04.013","volume":"5","author":"S Rathod","year":"2020","unstructured":"Rathod S, Dubey A, Chowdury A, Bashir B, Koul R (2020) A call for a radiation oncology model based on new 4Rs during the COVID-19 pandemic. Adv Radiat Oncol 5(4):608\u2013609","journal-title":"Adv Radiat Oncol"},{"issue":"10237","key":"7943_CR34","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ et al (2020) Hypofractionated breast radiotherapy for 1 week versus 3 weeks (fast-forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet 395(10237):1613\u20131626","journal-title":"Lancet"},{"issue":"6","key":"7943_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/wvn.12546","volume":"18","author":"BM Melnyk","year":"2021","unstructured":"Melnyk BM (2021) The current research to evidence-based practice time gap is now 15 instead of 17 years: urgent action is needed. Worldviews Evid Based Nurs 18(6):318\u2013319","journal-title":"Worldviews Evid Based Nurs"},{"issue":"7","key":"7943_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M et al (2019) Trastuzumab Emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380(7):617\u2013628","journal-title":"N Engl J Med"},{"issue":"3","key":"7943_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10549-025-07750-2","volume":"212","author":"LN Cohen","year":"2025","unstructured":"Cohen LN, Rogers CC, Lloren JIC, Kamaraju S, Chaudhary LN, Huang CC et al (2025) National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016-2021: the impact of the katherine trial. Breast Cancer Res Treat 212(3):531\u2013543","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7943_CR38","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/curroncol28020127","volume":"28","author":"T Tse","year":"2021","unstructured":"Tse T, Sehdev S, Seely J, Gravel DH, Clemons M, Cordeiro E et al (2021) Neoadjuvant chemotherapy in breast cancer: review of the evidence and conditions that facilitated its use during the global pandemic. Curr Oncol 28(2):1338\u20131347","journal-title":"Curr Oncol"},{"issue":"7","key":"7943_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"IH Kunkler","year":"2023","unstructured":"Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM (2023) Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med 388(7):585\u2013594","journal-title":"N Engl J Med"},{"issue":"19","key":"7943_CR40","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382\u20132387","journal-title":"J Clin Oncol"},{"key":"7943_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087","journal-title":"BMJ"},{"issue":"11","key":"7943_CR42","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/jnci\/djab097","volume":"113","author":"O Alagoz","year":"2021","unstructured":"Alagoz O, Lowry KP, Kurian AW, Mandelblatt JS, Ergun MA, Huang H et al (2021) Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. J Natl Cancer Inst 113(11):1484\u20131494","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"7943_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043828","volume":"10","author":"AG Lai","year":"2020","unstructured":"Lai AG, Pasea L, Banerjee A, Hall G, Denaxas S, Chang WH et al (2020) Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open 10(11):e043828","journal-title":"BMJ Open"},{"issue":"6","key":"7943_CR44","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/S2468-2667(22)00090-1","volume":"7","author":"Q Luo","year":"2022","unstructured":"Luo Q, O\u2019Connell DL, Yu XQ, Kahn C, Caruana M, Pesola F et al (2022) Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health 7(6):e537\u2013e548","journal-title":"Lancet Public Health"},{"issue":"11","key":"7943_CR45","doi-asserted-by":"publisher","first-page":"E408","DOI":"10.1503\/cmaj.202380","volume":"194","author":"A Parmar","year":"2022","unstructured":"Parmar A, Eskander A, Sander B, Naimark D, Irish JC, Chan KKW (2022) Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study. CMAJ 194(11):E408\u2013E414","journal-title":"CMAJ"},{"issue":"10","key":"7943_CR46","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S1470-2045(21)00426-5","volume":"22","author":"ZJ Ward","year":"2021","unstructured":"Ward ZJ, Walbaum M, Walbaum B, Guzman MJ, de la Jimenez Jara J, Nervi B et al (2021) Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis. Lancet Oncol 22(10):1427\u20131437","journal-title":"Lancet Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07943-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:36:22Z","timestamp":1777880182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07943-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7943"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07943-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Manitoba\u2019s Health Research Ethics Board (HS23979; H2020:264), Manitoba Health\u2019s Provincial Health Research Privacy Committee (2020\/2021-16), and CCMB\u2019s Research and Resource Impact Committee (2020-14). This study follows STROBE reporting guidelines for observational studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"7"}}